BIICX
Price
$10.48
Change
+$0.01 (+0.10%)
Updated
Jul 25 closing price
Net Assets
10.49B
UGTAX
Price
$28.39
Change
+$0.07 (+0.25%)
Updated
Jul 25 closing price
Net Assets
849.3M
Interact to see
Advertisement

BIICX vs UGTAX

Header iconBIICX vs UGTAX Comparison
Open Charts BIICX vs UGTAXBanner chart's image
BlackRock Multi-Asset Income Instl
Price$10.48
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets10.49B
Victory Growth and Tax Strategy A
Price$28.39
Change+$0.07 (+0.25%)
VolumeN/A
Net Assets849.3M
BIICX vs UGTAX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIICX has more cash in the bank: 10.5B vs. UGTAX (849M). BIICX pays higher dividends than UGTAX: BIICX (5.89) vs UGTAX (1.54). BIICX was incepted earlier than UGTAX: BIICX (17 years) vs UGTAX (5 years). UGTAX (0.91) is less costly to investors than BIICX (0.68). BIICX is a more actively managed with annual turnover of: 83.00 vs. UGTAX (17.00). UGTAX has a lower initial minimum investment than BIICX: UGTAX (2500) vs BIICX (2000000). BIICX annual gain was more profitable for investors over the last year : 10.19 vs. UGTAX (7.81). UGTAX return over 5 years is better than : 42.02 vs. BIICX (28.67).
BIICXUGTAXBIICX / UGTAX
Total Expense Ratio0.570.8369%
Annual Report Gross Expense Ratio0.680.9175%
Fund Existence17 years5 years-
Gain YTD6.9453.143221%
Front LoadN/A2%-
Min. Initial Investment2000000250080,000%
Min. Initial Investment IRAN/AN/A-
Net Assets10.5B849M1,237%
Annual Yield % from dividends5.891.54383%
Returns for 1 year10.197.81130%
Returns for 3 years27.0231.4086%
Returns for 5 years28.6742.0268%
Returns for 10 years58.36N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBSCX55.840.33
+0.59%
ClearBridge Select R
NSMAX32.730.17
+0.52%
Nuveen Small/Mid-Cap Value A
TCEPX44.570.19
+0.43%
Nuveen Equity Index Premier
PBQAX25.200.10
+0.40%
PGIM Jennison Blend A
JMNCX13.100.01
+0.08%
JPMorgan Research Market Neutral C